By the time I was 35 years old, I’d done everything society had told me to do…
At 23, I’d made it to the top of Wall Street and had become the youngest vice president in history at one of the most prestigious investment firms.
In 1998, before the internet really took off, I had a hunch and bought Beer.com for $80,000. Two months later, I sold it for $7 million – an 8,650% return on my initial capital.
I went on to own many of the world’s top domain names, including CreditCards.com, Music.com, and Diamond.com… I even had my own Super Bowl ad in 2000.
I traveled the world, started a family, and lived in a beautiful home…
I should’ve felt totally fulfilled… But I still felt like something was missing. Some might call it a spiritual mid-life crisis.
I’ve been fortunate to call many wonderful and well-connected people my friends, so I called the one friend I thought could give me the best guidance: spiritual icon and bestselling author Deepak Chopra.
Deepak helped me see that I’d spent my whole life focusing on external accomplishments.
If I really wanted to find answers and fulfillment, he said I would have to look within…
And what he suggested took me entirely by surprise.
He said I should travel deep into the jungles of Peru to sit with a shaman and experience the cultural tradition of plant-based medicines that dates back thousands of years.
I’d never done anything like that before, so I was skeptical… But Deepak was a close friend and also highly intelligent and respected.
And because I was feeling so disengaged from my life, I knew I’d have to try something off the radar to find fulfillment.
So when I decided to take the leap, I invited my friend Michelle Rodriguez, actress of the Fast and Furious movie franchise, to join me on the journey.
Our life-changing adventure became the award-winning documentary film that I directed called The Reality of Truth, which has now been viewed by more than 15 million people worldwide.
And my experience with plant-based psychedelic therapeutics was more transformational than I ever could’ve imagined.
An Asset Class That Will Change the World
Before I tell you my story, let me introduce myself. My name is Mike Zapolin, but my friends call me Zappy.
When I returned from the jungle, I felt healed, rejuvenated, and connected to life in a new way.
Through my experience in the Peruvian jungle, I lost my fear of death and discovered answers for many of the questions I had about what to do with the rest of my life…
I also immersed myself in learning as much as possible about the science behind these ancient medicines. I wanted everyone to know about these miraculous healing compounds.
However, I quickly realized that even if I could convince others to be open to the idea of psychedelic therapeutics, very few would be able (or willing) to travel to the jungle to access these medicines.
So, I made it my life’s mission to increase accessibility to these incredible compounds through education, research, clinical development, and commercial enterprises.
More than a decade later, I’m honored to be considered a top thought-leader in the psychedelic industry.
Today, my reputation as the “psychedelic concierge to the stars” grants me advanced insight into cutting-edge products and new investment opportunities.
And my experience has allowed me to help even more people…
My latest documentary, Lamar Odom Reborn, follows the former NBA and reality TV star’s psychedelic intervention to help break his addictions and lifelong anxiety.
The film is already a global phenomenon, with media coverage on Good Morning America, People Magazine, and Business Insider… and it’s allowed me to share the benefits of psychedelic medicines with millions of viewers worldwide.
Sure, there have been plenty of skeptics and doubt… but that’s nothing I haven’t dealt with before.
As a well-known futurist for the past 30-plus years, I’ve identified megatrend categories like domain names in the 1990s and legal cannabis in the early 2000s…
And while many people initially resisted these paradigm shifts, I stayed the course and followed my own vision of what I saw coming.
Today, I see another massive trend approaching in psychedelic therapeutics… and by coupling my expertise in the psychedelic space with my Wall Street background, it’s been easy for me to analyze and select the best-of-breed companies.
I see what’s happening now, and I know what’s coming next… and all the public companies I’ve been recommending since 2019 are up over 100%, with one as high as 1,000%.
E-commerce… cryptocurrency…. cannabis… These have all proven to be incredible new asset classes.
But psychedelic therapeutics – with their proven medical and mental health benefits and the groundbreaking research and legal changes we’ll soon see – are poised to be the biggest one yet.
That’s why I decided to team up with Teeka Tiwari and Palm Beach Research Group.
So you can take your own piece of this new industry and its enormous returns… while also understanding just how important this industry will become.
A $3 Trillion Problem
Based on our research, we estimate mental health disorders cost society $3 trillion per year in medical expenses and lost productivity.
Psychedelic therapies will not only address this global epidemic, but they’ll also reshape the way we think about medicine, mental health treatments, and investments in the space.
Because psychedelic therapeutics are still in their early stages, individual investors have an advantage over institutions that can only invest in companies on a major exchange.
And despite the early moves psychedelic stocks have already made, there’s still plenty more upside to go… A slew of new companies are coming to the market this year, some of which will be blockbusters.
If you’re looking to take advantage of the opportunity in psychedelic therapeutics, my advice is to get positioned right now… before the big Wall Street institutions can participate.
The intellectual property already held by these early psychedelic companies will disrupt a large share of the pharmaceutical industry, including many antidepressants, pain relievers, and addiction treatments.
This will be the next trillion-dollar industry.
And unlike cannabis, which has taken years to roll out, the mental health crisis and COVID-19 pandemic have accelerated the adoption of these new psychedelic compounds… They’re now seen as medicinal rather than recreational.
And this isn’t just conjecture or forecasts. I know this first-hand…
The CEOs of psychedelic companies regularly call on me for my business advice on strategic direction and acquisitions.
It’s important to differentiate the top management teams with the best intellectual property from companies that are simply jumping into the space to try to grab a piece of the gold rush.
And thanks to my experience and connections, I’ve developed the skill and insight to do just that.
The medicinal benefits of psychedelic compounds are in the zeitgeist today, creating a once-in-a-lifetime moment to own your piece of the space before it goes full-on mainstream.
Make sure you don’t miss out… The time is now, and the opportunity is massive.
P.S. Like I mentioned above, I joined Teeka to help you take your piece of this new industry and the enormous returns that await you.
And last night, Teeka and I announced the launch of a new publication we believe will help you get into this trend early and position you in the right companies to play it.
Teeka and I think this trend will be so massive, it could possibly be his third trillion-dollar trade.
Teeka’s first trillion-dollar trade was in 2003 when he identified Apple, the world’s first trillion-dollar company. His second trillion-dollar trade happened when he found cryptocurrencies in 2016 – today worth over $1 trillion.
And during our special event last night, Teeka and I explained why we believe medicinal psychedelics will be his third… You can watch the replay right here.